Results 141 to 150 of about 67,650 (239)

Investigation of Teratogenic Concerns in the Coronavirus Disease of 2019 Era

open access: yesBirth Defects Research, Volume 118, Issue 2, February 2026.
ABSTRACT Background MotherToBaby (MTB) is a teratogen information service that provides information about exposures during pregnancy and breastfeeding to the public and healthcare providers. During the Coronavirus Disease of 2019 (COVID‐19) pandemic, MTB received an influx of queries regarding the teratogenicity of the virus and the vaccine.
Kate Richardson   +6 more
wiley   +1 more source

Zika virus infection: Past and present of another emerging vector-borne disease

open access: yesJournal of Vector Borne Diseases, 2016
Zika virus infection is an emerging mosquito-borne disease, first identified in Uganda in 1947. It is caused by the Zika arbovirus, and transmitted by the bites of infected mosquitoes of the genus Aedes.
Hercules Sakkas   +2 more
doaj  

High Prevalence of Active HDV Infection Among HBsAg‐Positive Patients in Urban and Rural Areas in Gabon: A Cross‐Sectional Retrospective Study

open access: yesHealth Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background HDV, a defective virus dependent on hepatitis B for assembly, can lead to severe liver diseases and an increased risk of progressing to complications such as hepatocellular carcinoma. Given the high prevalence of HDV in Gabon, especially in central Africa, understanding the epidemiology and associated risks is crucial.
Berthold Bivigou‐Mboumba   +13 more
wiley   +1 more source

One year after the Zika virus outbreak in Brazil: from hypotheses to evidence

open access: yesRevista da Sociedade Brasileira de Medicina Tropical
Zika virusis an arbovirus of the Flaviviridae family with two major strains, an Asian and an African strain. The main vectors involved in the transmission of Zika virus are the Aedes aegypti and Aedes albopictus mosquitoes.
Carlos Alexandre Antunes de Brito   +1 more
doaj   +1 more source

Mosquito‐Borne Viruses of Clinical Significance

open access: yesHealth Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background Mosquito‐borne viruses represent a significant public health concern globally, with rising incidence rates leading to increased morbidity and mortality. This review aims to synthesize current knowledge regarding mosquito‐borne viruses, focusing on their geographic distribution, clinical impact, diagnostic challenges, treatment ...
Donath Damian
wiley   +1 more source

Prevention for Zika Virus Infection

open access: yesInternational Journal of Preventive Medicine, 2019
Pathum Sookaromdee, Viroj Wiwanitkit
openaire   +3 more sources

Zika Virus Infection, Philippines, 2012 [PDF]

open access: yesEmerging Infectious Diseases, 2020
Corazon Cerilla Buerano   +10 more
openaire   +3 more sources

Accelerate the Highly Efficient Development of mRNA Vaccines Through Advanced Computational Methods

open access: yesMedComm, Volume 7, Issue 2, February 2026.
This review explores the recent advancements in applying computational methods to optimize mRNA vaccines, with a primary focus on improvements in sequence design and delivery systems. ABSTRACT mRNA medicine is an emerging therapeutic approach that utilizes messenger RNA to synthesize functional proteins directly within target cells.
Ruichu Gu   +5 more
wiley   +1 more source

Toward Dual‐Function Nanoparticle Platforms for Arboviral Diagnostics and Vaccines: Advances, Challenges, and Future Prospects

open access: yesNano Select, Volume 7, Issue 2, February 2026.
This review explores nanoparticle (NP)‐based biosensors and nanovaccine platforms for arboviral infections, highlighting their design, performance, and translational potential. By comparing case studies across viruses, it identifies gold‐standard nanomaterials such as gold NPs (AuNPs), zinc oxide NPs (ZnONPs), molybdenum disulfide (MoS2) nanocomposites,
Peyman Halvaeikhanekahdani   +3 more
wiley   +1 more source

Novel Wide‐Spectrum Virucidal Lipid Nanoparticles

open access: yesSmall, Volume 22, Issue 7, 2 February 2026.
POSTAN is a novel broad‐spectrum antiviral nanoparticle that combines safety with potent virucidal activity. Composed of biocompatible lipids, it mimics heparan sulfate proteoglycans and lipid rafts exploited by viruses, thereby dismantling viral envelopes and blocking replication.
Yugo Araújo Martins   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy